Blackstone Inc’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Blackstone Inc’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-815,000	Closed	-$9.27M	–	205
2023 Q4	$9.27M	Buy	+815,000	New	+$6.41M	0.04%	72

Blackstone Inc's HARP Position: Q1 2024 in Review

Blackstone Inc sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 815,000 shares — an estimated $9.27M sold.

Blackstone Inc first reported a position in HARP in Q4 2023 and held it in 1 quarter. The position peaked at $9.27M in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Blackstone Inc reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Blackstone Inc sold 815,000 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $9.27M.
Blackstone Inc first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Blackstone Inc's Harpoon Therapeutics, Inc. Common Stock position peaked at $9.27M in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Blackstone Inc's 13F filing for Q1 2024, filed 15 May 2024.